Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > A New Old Therapy: A controlled phage therapy can target drug-resistant bacteria while sidestepping potential unintended consequences

Abstract:
The fight against drug-resistant pathogens remains an intense one. While the Centers for Disease Control’s (CDC) 2019 “biggest threats” report reveals an overall decrease in drug-resistant microbe-related deaths as compared to its previous report (2013) the agency also cautions that new forms of drug-resistant pathogens are still emerging.

A New Old Therapy: A controlled phage therapy can target drug-resistant bacteria while sidestepping potential unintended consequences

Santa Barbara, CA | Posted on January 13th, 2020

Meanwhile, the options for treating infections by these germs are diminishing, confirming doctors’ and scientists’ worries about the end of the age of antibiotics.

“We knew it was going to be a problem early on,” said UC Santa Barbara chemistry and biochemistry professor Irene Chen. “Basically as soon as penicillin was discovered, a few years later it was reported that there was a resistant organism.” Thanks to factors such as horizontal gene transfer and rapid reproduction, organisms such as Gram-negative bacteria are able to evolve faster than we can produce antibiotics to control them.

So Chen and her research group are seeking alternatives to antibiotics, in a growing effort to head off the tide of incurable bacterial infections. In their work, the group has turned to bacteriophages, a naturally occurring group of viruses that colonize on bacteria.

“That’s their natural function, really, to grow on and kill bacteria,” said Chen, author of a paper that appears in the Proceedings of the National Academy of Sciences. By taking advantage of the bacteriophages’ ability to home in on specific bacteria without damaging the rest of the microbiome, the researchers were able to use a combination of gold nanorods and near-infrared light to destroy even multidrug-resistant bacteria without antibiotics.

Phage therapy isn’t new, Chen said. In fact, it has been used in the former Soviet Union and Europe for about a century, though they are seen largely as last-resort alternatives to antibiotics. Among the unresolved issues of phage therapy is the incomplete characterization of the phages’ biology — a biology that could allow for unintended consequences due to the phages’ own rapid evolution and reproduction, as well as potential toxins the viruses may carry. Another issue is the all-or-nothing aspect of phage therapy, Chen added.

“It’s difficult to analyze the effect of a phage treatment,” she said. “You might see it completely work or you might see it completely fail, but you don’t have the kind of dose response you want.”

To surmount these challenges, the Chen lab developed a method of controlled phage therapy.

“What we did was to conjugate the phages to gold nanorods,” she explained. These “phanorods” were applied to bacteria on in-vitro cultures of mammalian cells and then exposed to near-infrared light.

“When these nanorods are photo-excited, they translate the energy from light to heat,” Chen said, “and that creates very high local temperatures.”

The heat is enough to kill the bacteria, and it also kills the phages, preventing any unwanted further evolutions. The result is a guided missile of targeted phage therapy that also allows for dosage control. The lab found success in destroying E. coli, P. aeruginosa and V. cholerae — human pathogens that cause acute symptoms if left unchecked. They also were able to successfully destroy X. campestris, a bacteria that causes rot in plants.

In a collaboration with UC Santa Barbara mechanical engineer Beth Pruitt, the lab determined that while the heat successfully destroyed bacteria and phage, more than 80% of the mammalian cell culture underneath the bacteria biofilm survived.

“This issue of whether it damages mammalian tissues is very important,” Chen said. “Work in nanotechnology and nanomedicine treating bacterial infections indicates that when it’s non-targeted, it really does burden the surrounding tissues.”

The lab plans to investigate other possible phages to counter other bacteria, possibly engineering a photothermal method that could treat multiple bacterial infections.

Research on this study was conducted also by UCSB postdoctoral fellow Huan Peng (lead author), Raymond E. Borg and Liam P. Dow.

####

For more information, please click here

Contacts:
Sonia Fernandez
(805) 893-4765

Shelly Leachman
(805) 893-8726

Copyright © University of California, Santa Barbara

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

When Dirac meets frustrated magnetism August 3rd, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Scientists discover new class of semiconducting entropy-stabilized materials July 31st, 2020

Possible Futures

Physicists find misaligned carbon sheets yield unparalleled properties July 31st, 2020

Way, shape and form: Synthesis conditions define the nanostructure of manganese dioxide July 31st, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

Scientists discover new class of semiconducting entropy-stabilized materials July 31st, 2020

Nanomedicine

Izon Science receives $10.5M investment from Bolton Equities: Christchurch-headquartered nanotech company secures investment to accelerate global growth; appoints top board chairman and directors July 28th, 2020

Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis July 28th, 2020

Silver-plated gold nanostars detect early cancer biomarkers: New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues July 24th, 2020

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

Discoveries

When Dirac meets frustrated magnetism August 3rd, 2020

Way, shape and form: Synthesis conditions define the nanostructure of manganese dioxide July 31st, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Announcements

When Dirac meets frustrated magnetism August 3rd, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Scientists discover new class of semiconducting entropy-stabilized materials July 31st, 2020

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

When Dirac meets frustrated magnetism August 3rd, 2020

Way, shape and form: Synthesis conditions define the nanostructure of manganese dioxide July 31st, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Nanobiotechnology

Izon Science receives $10.5M investment from Bolton Equities: Christchurch-headquartered nanotech company secures investment to accelerate global growth; appoints top board chairman and directors July 28th, 2020

Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis July 28th, 2020

Silver-plated gold nanostars detect early cancer biomarkers: New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues July 24th, 2020

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project